Login / Signup

Risk Factors for Denosumab Discontinuation in Patients with Postmenopausal Osteoporosis.

Kyosuke HattoriNobunori TakahashiToshihisa KojimaShiro Imagama
Published in: Modern rheumatology (2022)
A low BMI, low serum Alb levels, and a high number of VFs were associated with denosumab discontinuation in patients with PMO.
Keyphrases
  • bone mineral density
  • postmenopausal women
  • body composition
  • giant cell
  • physical activity
  • weight loss